Drugs / S. sonnei O-SP-rEPA conjugate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00368316 | Jan 2003 → Jan 2008 | shigellosis | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | S. sonnei O-SP-rEPA conjugate | “S. sonnei O-SP-rEPA conjugate.” NCT00368316 ↗ |
| Known as | Shigella sonnei-rEPA | “Shigella sonnei-rEPA and Shigella flexneri2a rEPA vaccines” NCT00368316 ↗ |
| Modality | Vaccine | “Shigella sonnei-rEPA and Shigella flexneri2a rEPA vaccines” NCT00368316 ↗ |
| Route | Intramuscular | “25 microg, injected IM twice” PMID 20056180 ↗ Jan 2010 |